Profil
Mark Levick served as Global Head-Development at Sandoz Biopharmaceuticals from 2016 to 2019.
Dr. Levick was Chief Executive Officer at Alvotech from 2019 to 2023.
Dr. Levick was Chief Executive Officer & Director at InterAx Biotech AG from 2023 to 2025.
Dr. Levick was Chief Executive Officer at Alvotech hf.
Dr. Levick was Global Head at Novartis AG.
Dr. Levick earned a doctorate from the University of Cambridge and completed undergraduate studies at The University of Newcastle.
Tidigare kända positioner av Mark Levick
| Företag | Position | Slut |
|---|---|---|
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops a platform for discovery of functionally selective drugs | Verkställande Direktör | 2025-10-17 |
| ALVOTECH | Verkställande Direktör | 2023-01-01 |
Sandoz Biopharmaceuticals | Företagsledare/Principal | 2019-01-01 |
| NOVARTIS AG | Företagsledare/Principal | 2016-07-01 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Verkställande Direktör | - |
Mark Levicks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Newcastle
The University of Newcastle Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops a platform for discovery of functionally selective drugs | Commercial Services |
Alvotech
Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
Sandoz Biopharmaceuticals |
















